The Management

The management team has a strong track record in corporate development and technology commercialisation.
 

Mr. Ian Brown

MBA FAICD FAIM

Managing Director & CEO

Ian is the Managing Director and CEO of SDP Technology Ltd and the Managing Director of Avanti Capital. Ian is also a non executive director on a number of boards and has served as Chair and deputy Chair. Ian has lived and worked in Australia and Europe, and has worked on secondment on various projects in the United States and Asia. Prior to his current roles, Ian held senior executive positions with Chromogenix (previously Kabi Pharmacia) in Gothenburg Sweden, Instrumentation Laboratory in Milan Italy and several companies in Australia. In addition to his significant international corporate and business experience, Ian has led teams in M&A and JV transactions and post deal integration. His experience also covers start-ups, divestments and spin-outs, as well as private and public company capital raisings and IPO’s. Ian is a member of the Course Advisory Committee for the Masters of Entrepreneurship and Innovation Degree at the Australian Graduate School of Entrepreneurship (AGSE). Ian has an MBA and is a Fellow of both the Australian Institute of Company Directors and Australian Institute of Management, and is an alumnus of both INSEAD in France and MBS in Australia.
 

Dr. Murray Tait

PhD BA (Hons)

COO

Murray Tait has more than 25 years of industry experience in drug discovery, including 14 years with Glaxo in the UK (now GSK) and 1 year with Glaxo in Singapore, where he acted as scientific consultant overseeing establishment of the Centre for Natural Products Research in the premises of Singapore's Institute of Molecular and Cell Biology. In 1994 he joined the Australian biotechnology company AMRAD as the first employee of a newly-created subsidiary company AMRAD Natural Products Pty Ltd, which was subsequently spun out of the AMRAD group and established as a new company, Cerylid Pty Ltd, in 2000. Murray remained with Cerylid as Vice President, Drug Discovery until June 2006. He holds a BA in Biochemistry (First Class Honours) from Stirling University and a PhD from The University of Edinburgh Medical School in Scotland.
 

Mrs. Jacqueline Butler

BA CA

Chief Financial Officer

Jacqueline Butler is a Qualified Chartered Accountant. Jacqueline has a significant amount of experience having managed her own business in the UK and prior to that been a financial controller as well as working in banking in a relationship management capacity. She qualified and spent 4 years working within the Audit division of Arthur Andersen, London, UK. Jacqueline works closely with Azure Group clients to ensure their financial and management records are up to date on a monthly basis as well as being heavily involved in the strategic management of client affairs in a CFO capacity.
 

Mr. Michael Zhu

Management Accountant

Michael Zhu has over 6 years experience within the commercial accounting field. Having recently completed his degree he has joined the team to provide financial and management accounting support to the Chief Financial Officers. Michael's strengths lie in his system skills, and financial accounting knowledge. Michael is currently completing his Chartered Accounting qualifications.